| abstract |
The invention provides methods for generating human antibodies with the specificity of a reference antibody by replacement of portions of the V H and V L sequences of the reference antibody with sequences from human antibody repertoires. The invention also provides novel compositions comprising hybrid immunoglobulin variable domains containing a combination of frameworks (FRs) and CDRs from different antibody clones. |